These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 23587465)
21. First clinical experience with the GARDEX EPD: a novel embolic protection device for carotid artery stenting. Werner M; Scheinert D; Borghesi R; Cremonesi A; Rosenschein U; Scheinert S; Bräunlich S; Bausback Y; Ulrich M; Schmidt A EuroIntervention; 2013 Jan; 8(9):1026-32. PubMed ID: 23339808 [TBL] [Abstract][Full Text] [Related]
22. Update on new stents and protection devices for carotid artery stenting: what we know, what we learnt recently and what we need to know. Nikas DN; Makos X; Umemoto T; Liappas G; Pacchioni A; Zakarian N; Reimers B J Cardiovasc Surg (Torino); 2017 Feb; 58(1):13-24. PubMed ID: 27922252 [TBL] [Abstract][Full Text] [Related]
23. Asymptomatic carotid artery stenting: Filter or no filter? Cilingiroglu M Catheter Cardiovasc Interv; 2012 Jul; 80(1):120. PubMed ID: 22736591 [No Abstract] [Full Text] [Related]
24. Evidence overview: benefit of cerebral protection devices during carotid artery stenting. Vos JA J Cardiovasc Surg (Torino); 2017 Apr; 58(2):170-177. PubMed ID: 28004899 [TBL] [Abstract][Full Text] [Related]
25. Feasibility, safety, and early outcomes of direct carotid artery stent implantation with use of the FilterWire EZ Embolic Protection System. Veselka J; Cerná D; Zimolová P; Martinkovicová L; Fiedler J; Hájek P; Malý M; Zemánek D; Duchonová R Catheter Cardiovasc Interv; 2009 May; 73(6):733-8. PubMed ID: 19198010 [TBL] [Abstract][Full Text] [Related]
26. Proving the safety of carotid artery stenting: now or never. Roffi M; Cremonesi A; Setacci C J Endovasc Ther; 2012 Dec; 19(6):757-60. PubMed ID: 23210873 [No Abstract] [Full Text] [Related]
27. Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Clair DG; Hopkins LN; Mehta M; Kasirajan K; Schermerhorn M; Schönholz C; Kwolek CJ; Eskandari MK; Powell RJ; Ansel GM; Catheter Cardiovasc Interv; 2011 Feb; 77(3):420-9. PubMed ID: 20853365 [TBL] [Abstract][Full Text] [Related]
28. The Role of Embolic Protection in Carotid Stenting Progress in Cardiovascular Diseases (PCVD). Kobayashi T; Giri J Prog Cardiovasc Dis; 2017; 59(6):612-618. PubMed ID: 28372946 [TBL] [Abstract][Full Text] [Related]
29. Reduction of postprocedure microemboli following retrospective quality assessment and practice improvement measures for carotid angioplasty and stenting. Tedesco MM; Dalman RL; Zhou W; Coogan SM; Lane B; Lee JT J Vasc Surg; 2009 Mar; 49(3):607-12; discussion 612-3. PubMed ID: 19135833 [TBL] [Abstract][Full Text] [Related]
31. Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study. Pinter L; Ribo M; Loh C; Lane B; Roberts T; Chou TM; Kolvenbach RR J Vasc Surg; 2011 Nov; 54(5):1317-23. PubMed ID: 21658889 [TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors of embolized particles in carotid artery stenting and association with clinical outcome. Ledwoch J; Staubach S; Segerer M; Strohm H; Mudra H Int J Cardiol; 2017 Jan; 227():550-555. PubMed ID: 27829527 [TBL] [Abstract][Full Text] [Related]
34. Embolic protection devices for carotid artery stenting: have they made a significant difference in outcomes? Atkins MD; Bush RL Semin Vasc Surg; 2007 Dec; 20(4):244-51. PubMed ID: 18082841 [TBL] [Abstract][Full Text] [Related]
35. The impact of embolic protection device and stent design on the outcome of CAS. Bosiers M; Deloose K; Verbist J; Peeters P Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):272-9. PubMed ID: 18930936 [TBL] [Abstract][Full Text] [Related]